Primary Job Title CEO Primary Organization 
GrandOmics
Location Changping, Beijing, China Regions Asia-Pacific (APAC) Gender Male
LinkedIn View on LinkedIn
As a senior in the field of sequencing, he started the application of Sanger sequencing technology in 2000 and has been engaged in the application of next generation sequencing technology since 2007, including early incubation and promotion of NIPT, PGD/PGS, HLA typing, whole exome sequencing and so on. With the development of third-generation
sequencing technology, he started sequencing services based on third-generation sequencing technology in 2012 and initiated and participated in the completion of the first near complete reference Chinese human genome“HuaXia1(HX1)” led by professor Wang kai and Su guohui. Since 2016, he has been engaged in research on Chinese structural variation data and participated in several major research projects based on third-generation sequencing technology.
